APA (7th ed.) Citation

Lago, N. M., Lopez, B. C., Gomez, J. D. l. C., Vázquez-Rivera, F., Montes, A. F., Dios, N. d., . . . Ínsua, Y. V. (2020). P-123 Outcomes and predictive factors of regorafenib benefit in patients with metastatic colorectal cancer in a real-life setting. Annals of Oncology, 31, S130. https://doi.org/10.1016/j.annonc.2020.04.205

Chicago Style (17th ed.) Citation

Lago, N. Martínez, et al. "P-123 Outcomes and Predictive Factors of Regorafenib Benefit in Patients with Metastatic Colorectal Cancer in a Real-life Setting." Annals of Oncology 31 (2020): S130. https://doi.org/10.1016/j.annonc.2020.04.205.

MLA (9th ed.) Citation

Lago, N. Martínez, et al. "P-123 Outcomes and Predictive Factors of Regorafenib Benefit in Patients with Metastatic Colorectal Cancer in a Real-life Setting." Annals of Oncology, vol. 31, 2020, p. S130, https://doi.org/10.1016/j.annonc.2020.04.205.